Summary
- Lonza Group AG has entered into a definitive agreement to sell its Capsules & Health Ingredients (CHI) business to Lone Star Funds for an enterprise value of CHF 2.3 billion ($3 billion).
- TT&A provided legal advice to Lonza specifically for the India-leg of this significant business transfer.
- The transaction marks a major strategic move for both Lonza and Lone Star Funds in the health ingredients sector.
- This sale could reshape market dynamics, highlighting the growing interest in health-related businesses.
Join the discussion ā sign up to comment, upvote, and save articles.